Pages that link to "Q28204276"
Jump to navigation
Jump to search
The following pages link to Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients (Q28204276):
Displaying 50 items.
- Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications (Q26778222) (← links)
- New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer (Q26786311) (← links)
- An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? (Q27024427) (← links)
- (Q28159952) (redirect page) (← links)
- Rectal cancer staging (Q30484651) (← links)
- Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial (Q33438899) (← links)
- Neo-adjuvant chemoradiotherapy; an opportunity in sphincter preserving procedure for rectal cancer. (Q33596791) (← links)
- Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer (Q33637997) (← links)
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data (Q33652239) (← links)
- Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy (Q33820817) (← links)
- Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy (Q33997798) (← links)
- The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery. (Q34101866) (← links)
- Rectal cancer treatment: improving the picture. (Q34382761) (← links)
- Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors. (Q34599442) (← links)
- Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma. (Q34743494) (← links)
- Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer (Q34932625) (← links)
- Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer. (Q34989668) (← links)
- Molecular Diagnosis of Response to Neoadjuvant Chemoradiation Therapy in Patients with Locally Advanced Rectal Cancer (Q35013576) (← links)
- Pathologic response of primary rectal cancer to oxaliplatin-based chemotherapy (Q35117930) (← links)
- Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer (Q35460703) (← links)
- Radiotherapy and Oral Capecitabine in the Preoperative Treatment of Patients with Rectal Cancer: Rationale, Preliminary Results and Perspectives (Q35579304) (← links)
- Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer (Q35623320) (← links)
- Intraoperative radiotherapy in the multimodality approach to colorectal cancer (Q35677768) (← links)
- Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: Results from a prospective study (Q35758067) (← links)
- Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer. (Q36216917) (← links)
- Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. (Q36263852) (← links)
- Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging (Q36343876) (← links)
- Preoperative versus postoperative treatment for locally advanced rectal carcinoma (Q36429439) (← links)
- Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer (Q36646705) (← links)
- A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators (Q36903261) (← links)
- Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules (Q37079063) (← links)
- Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients (Q37119089) (← links)
- Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome (Q37131682) (← links)
- Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer (Q37140736) (← links)
- Neoadjuvant treatment of rectal cancer: where are we now? (Q37158143) (← links)
- Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation. (Q37238569) (← links)
- Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety (Q37311450) (← links)
- Abdominoperineal resection: how is it done and what are the results? (Q37462249) (← links)
- Chemoradiotherapy response in recurrent rectal cancer (Q37595254) (← links)
- Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer (Q37686375) (← links)
- Chemoradiation for Rectal Cancer: Rationale, Approaches, and Controversies (Q37795270) (← links)
- Counterpoint: Long-Course Chemoradiation Is Preferable in the Neoadjuvant Treatment of Rectal Cancer (Q37885525) (← links)
- Unique Considerations in the Patient With Rectal Cancer (Q37910391) (← links)
- Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy? (Q37955677) (← links)
- Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy (Q38079162) (← links)
- Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer? (Q38208009) (← links)
- Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results? (Q38236794) (← links)
- T4 rectal cancer: do we always need an exenteration? (Q38237877) (← links)
- Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy? (Q38464448) (← links)
- Possible role of nuclear β-catenin in resistance to preoperative chemoradiotherapy in locally advanced rectal cancer. (Q38709210) (← links)